Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

50 results
Display

Rate of premalignant and malignant endometrial lesion in “low-risk” premenopausal women with abnormal uterine bleeding undergoing endometrial biopsy

Jha S, Singh A, Sinha HH, Bhadani P, Anant M, Agarwal M

Objective To determine the incidence of endometrial hyperplasia and endometrial cancer (EH/EC) in low-risk premenopausal women with abnormal uterine bleeding (AUB) undergoing endometrial biopsy and to build a predictive model that...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Fertility-preserving treatment outcome in endometrial cancer or atypical hyperplasia patients with polycystic ovary syndrome

Wang L, Luo X, Wang Q, Lv Q, Wu P, Liu W, Chen X

Objective This study aimed to investigate the impact of polycystic ovary syndrome (PCOS) on fertility-sparing treatment in young patients with atypical endometrial hyperplasia (AEH) or endometrioid endometrial cancer (EEC). Methods A total of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Characteristics of progestin-insensitive early stage endometrial cancer and atypical hyperplasia patients receiving second-line fertility-sparing treatment

Zhou S, Xu Z, Yang B, Guan J, Shan W, Shi Y, Chen X

Objective This study investigated the characteristics of progestin-insensitive endometrioid endometrial cancer (EEC) and atypical endometrial hyperplasia (AEH) patients receiving fertility-sparing treatments and assessed the therapeutic effects of second-line fertility-preserving treatments. Methods Three hundred...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Non-atypical endometrial hyperplasia: risk factors for occult endometrial atypia and malignancy in patients managed with hysterectomy

Hui LS, Chin SHM, Goh C, Hui LX, Mathur M, Kuei TLY, Xian FCH

Objective To determine the risk factors for occult endometrial atypia and malignancy in patients diagnosed with non-atypical endometrial hyperplasia (NEH) on endometrial biopsy. Methods All new cases of NEH diagnosed between April 2015...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study

Kim MK, Seong SJ, Park DC, Hong JH, Roh JW, Kang SB

Objective: To compare the diagnostic accuracy of dilatation and curettage (D&C) versus endometrial aspiration biopsy in follow-up evaluation of patients treated with progestin for endometrial hyperplasia (EH) Methods: A prospective...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Endometrial thickness cut-off value by transvaginal ultrasonography for screening of endometrial pathology in premenopausal and postmenopausal women

Park YR, Lee SW, Kim Y, Bae IY, Kim HK, Choe J, Kim YM

OBJECTIVE: To assess the clinical usefulness and diagnostic accuracy of ultrasonographic measurement of endometrial thickness (ET) in women with endometrial hyperplasia or cancer (EH+). METHODS: This retrospective cohort study included 29,995...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients

Mitsuhashi A, Habu Y, Kobayashi , Kawarai Y, Ishikawa H, Usui H, Shozu M

OBJECTIVE: The present study investigated long-term outcomes of medroxyprogesterone acetate (MPA) plus metformin therapy in terms of control of atypical endometrial hyperplasia (AEH) and endometrial cancer (EC), and post-treatment conception. METHODS:...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Combined estrogen-progestin pill is a safe and effective option for endometrial hyperplasia without atypia: a three-year single center experience

Wang Y, Nisenblat , Tao L, Zhang X, Li H, Ma C

OBJECTIVE: To evaluate the effectiveness of oral contraceptive pill (OCP) as therapy for endometrial hyperplasia (EH) without atypia in reproductive-aged women compared with oral progestin. METHODS: A retrospective cohort study was...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Insulin resistance and overweight prolonged fertility-sparing treatment duration in endometrial atypical hyperplasia patients

Yang B, Xie L, Zhang H, Zhu Q, Du Y, Luo X, Chen X

OBJECTIVE: Our previous study showed that insulin resistance (IR) was related to endometrial hyperplasia as well as endometrial cancer. But the exact impact of IR on fertility-sparing treatment in endometrial...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?

Yamagami W, Susumu N, Makabe T, Sakai K, Nomura H, Kataoka F, Hirasawa A, Banno K, Aoki D

OBJECTIVE: Reports on the repeated administration of medroxyprogesterone acetate (MPA) for intrauterine recurrence after fertility-preserving therapy for atypical endometrial hyperplasia (AEH) and early grade 1 endometrioid carcinoma (G1) are lacking....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Histopathologic findings in uteri and ovaries collected from clinically healthy dogs at elective ovariohysterectomy: a cross-sectional study

Maya-Pulgarin D, Gonzalez-Dominguez MS, Aranzazu-Taborda D, Mendoza N, Maldonado-Estrada JG

Opinions on ovariohysterectomy (OHE) of bitches vary depending on region and country. In this descriptive, prospective cross-sectional study, uterine tracts and ovaries exhibiting gross pathologic findings (n = 76) were...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Endometrial evaluation with transvaginal ultrasonography for the screening of endometrial hyperplasia or cancer in premenopausal and perimenopausal women

Kim MJ, Kim JJ, Kim SM

OBJECTIVE: The aim of our study is to determine clinical factors and sonographic findings associated with endometrial hyperplasia or cancer (EH+) in premenopausal and perimenopausal women. METHODS: A total of 14,340...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Therapeutic options for management of endometrial hyperplasia

Chandra V, Kim JJ, Benbrook D, Dwivedi A, Rai R

Endometrial hyperplasia (EH) comprises a spectrum of changes in the endometrium ranging from a slightly disordered pattern that exaggerates the alterations seen in the late proliferative phase of the menstrual...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Fertility-preserving treatment in complex atypical hyperplasia and early endometrial cancer in young women with oral progestin: Is it effective?

Baek JS, Lee WH, Kang WD, Kim SM

OBJECTIVE: The aim of this study is to assess the effectiveness of oral progestin treatment in women diagnosed with complex atypical hyperplasia (CAH) or grade 1 endometrial cancer (G1EC), who...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Significance of miR-34a Expression in Endometrial Carcinogenesis: Correlation With Expression of p16 and Ki-67 Proteins in Endometrial Cancers

Choi YS, Lee KE

BACKGROUND: A microRNA, miR-34a, plays a key role in inhibiting cellular transformation and carcinogenesis by controlling cell cycle regulation and cell proliferation in various human tumors. However, miR-34a has rarely...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Endometrial cancer arising from atypical complex hyperplasia: The significance in an endometrial biopsy and a diagnostic challenge

Byun JM, Jeong DH, Kim YN, Cho EB, Cha JE, Sung MS, Lee KB, Kim KT

OBJECTIVE: We investigated the features of endometrial hyperplasia with concurrent endometrial cancer that had been diagnosed by endometrial sampling. Further, we attempted to identify an accurate differential diagnostic method. METHODS: We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Neutrophil-lymphocyte and platelet-lymphocyte ratios in endometrial hyperplasia

Cakmak B, Gulucu S, Aliyev N, Ozsoy Z, Nacar M, Koseoglu D

OBJECTIVE: The purpose of present study was to evaluate association between neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) and endometrial hyperplasia (EH). METHODS: One hundred and ten women with abnormal uterine...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical significance of mismatch repair genes immunohistochemical expression of complex endometrial hyperplasia

Han SJ, Kim MK

OBJECTIVE: Women with Lynch syndrome have an increased risk of developing colorectal and gynecologic malignancies such as endometrial cancer. Complex hyperplasia has about a 30% risk of developing into endometrial...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia

Shan W, Wang C, Zhang Z, Gu C, Ning C, Luo X, Zhou Q, Chen X

OBJECTIVE: To compare the efficacy of metformin plus megestrol acetate (MA) with that of MA alone for treating endometrial atypical hyperplasia (EAH). METHODS: This pilot study included 16 EAH patients who...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
LNG-IUS treatment of non-atypical endometrial hyperplasia in perimenopausal women: a randomized controlled trial

Abu Hashim H, Zayed A, Ghayaty E, El Rakhawy M

OBJECTIVE: To compare the efficacy of the levonorgestrel-releasing intrauterine system (LNG-IUS) and oral norethisterone acetate (NET) for treatment of non-atypical endometrial hyperplasia in perimenopausal women. METHODS: One hundred and twenty perimenopausal...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr